81 related articles for article (PubMed ID: 15072767)
21. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
23. Regulation of caspase-6 and FLIP by the AMPK family member ARK5.
Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Miyamoto S; Ogura T; Ochiai A; Esumi H
Oncogene; 2004 Sep; 23(42):7067-75. PubMed ID: 15273717
[TBL] [Abstract][Full Text] [Related]
24. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
25. P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells.
Tanel A; Averill-Bates DA
Cell Signal; 2007 May; 19(5):968-77. PubMed ID: 17196791
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
Boudreau RT; Conrad DM; Hoskin DW
Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
[TBL] [Abstract][Full Text] [Related]
27. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
28. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling.
Acconcia F; Totta P; Ogawa S; Cardillo I; Inoue S; Leone S; Trentalance A; Muramatsu M; Marino M
J Cell Physiol; 2005 Apr; 203(1):193-201. PubMed ID: 15389627
[TBL] [Abstract][Full Text] [Related]
29. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis stimulated by the 91-kDa caspase cleavage MEKK1 fragment requires translocation to soluble cellular compartments.
Schlesinger TK; Bonvin C; Jarpe MB; Fanger GR; Cardinaux JR; Johnson GL; Widmann C
J Biol Chem; 2002 Mar; 277(12):10283-91. PubMed ID: 11782455
[TBL] [Abstract][Full Text] [Related]
31. Targeting apoptotic and autophagic pathways for cancer therapeutics.
Liu JJ; Lin M; Yu JY; Liu B; Bao JK
Cancer Lett; 2011 Jan; 300(2):105-14. PubMed ID: 21036469
[TBL] [Abstract][Full Text] [Related]
32. Protein kinases curb cell death.
Filhol O; Cochet C
Sci Signal; 2011 May; 4(172):pe26. PubMed ID: 21558553
[TBL] [Abstract][Full Text] [Related]
33. Functional PAK-2 knockout and replacement with a caspase cleavage-deficient mutant in mice reveals differential requirements of full-length PAK-2 and caspase-activated PAK-2p34.
Marlin JW; Chang YW; Ober M; Handy A; Xu W; Jakobi R
Mamm Genome; 2011 Jun; 22(5-6):306-17. PubMed ID: 21499899
[TBL] [Abstract][Full Text] [Related]
34. Many cuts to ruin: a comprehensive update of caspase substrates.
Fischer U; Jänicke RU; Schulze-Osthoff K
Cell Death Differ; 2003 Jan; 10(1):76-100. PubMed ID: 12655297
[TBL] [Abstract][Full Text] [Related]
35. Novel extracellular and nuclear caspase-1 and inflammasomes propagate inflammation and regulate gene expression: a comprehensive database mining study.
Wang L; Fu H; Nanayakkara G; Li Y; Shao Y; Johnson C; Cheng J; Yang WY; Yang F; Lavallee M; Xu Y; Cheng X; Xi H; Yi J; Yu J; Choi ET; Wang H; Yang X
J Hematol Oncol; 2016 Nov; 9(1):122. PubMed ID: 27842563
[TBL] [Abstract][Full Text] [Related]
36. The role of oncogenic kinases in human cancer (Review).
Tsatsanis C; Spandidos DA
Int J Mol Med; 2000 Jun; 5(6):583-90. PubMed ID: 10812005
[TBL] [Abstract][Full Text] [Related]
37. Demystifying MST family kinases in cell death.
Lehtinen MK; Bonni A
Curr Mol Med; 2008 Jun; 8(4):313-8. PubMed ID: 18537638
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis: programmed cell death in health and disease.
Bright J; Khar A
Biosci Rep; 1994 Apr; 14(2):67-81. PubMed ID: 7948772
[TBL] [Abstract][Full Text] [Related]
39. Protein kinases and phosphorylation in neurologic disorders and cell death.
Saitoh T; Masliah E; Jin LW; Cole GM; Wieloch T; Shapiro IP
Lab Invest; 1991 May; 64(5):596-616. PubMed ID: 2030574
[No Abstract] [Full Text] [Related]
40. Oncogenic shock: turning an activated kinase against the tumor cell.
Sharma SV; Settleman J
Cell Cycle; 2006 Dec; 5(24):2878-80. PubMed ID: 17218790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
